Annual EBIT
-$77.06 M
+$70.64 M+47.83%
December 31, 2022
Summary
- As of February 10, 2025, SPPI annual earnings before interest & taxes is -$77.06 million, with the most recent change of +$70.64 million (+47.83%) on December 31, 2022.
- During the last 3 years, SPPI annual EBIT has risen by +$63.64 million (+45.23%).
Performance
SPPI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$4.06 M
+$11.94 M+74.62%
March 31, 2023
Summary
- As of February 10, 2025, SPPI quarterly earnings before interest & taxes is -$4.06 million, with the most recent change of +$11.94 million (+74.62%) on March 31, 2023.
- Over the past year, SPPI quarterly EBIT has increased by +$10.00 million (+71.11%).
Performance
SPPI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$67.06 M
+$10.00 M+12.98%
March 31, 2023
Summary
- As of February 10, 2025, SPPI TTM earnings before interest & taxes is -$67.06 million, with the most recent change of +$10.00 million (+12.98%) on March 31, 2023.
- Over the past year, SPPI TTM EBIT has increased by +$71.70 million (+51.67%).
Performance
SPPI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SPPI EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.8% | +71.1% | +51.7% |
| 3 y3 years | +45.2% | +86.8% | +49.8% |
| 5 y5 years | +33.5% | +79.7% | +52.3% |
SPPI EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.7% | at high | +1069.8% | at high | +136.2% |
| 5 y | 5-year | at high | +120.3% | at high | +1447.8% | at high | +168.7% |
| alltime | all time | -195.8% | +120.3% | -117.2% | +1447.8% | -183.0% | +168.7% |
Spectrum Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$4.06 M(-74.6%) | -$67.06 M(-13.0%) |
| Dec 2022 | -$77.06 M(-47.8%) | -$16.01 M(-25.9%) | -$77.06 M(-29.0%) |
| Sep 2022 | - | -$21.60 M(-14.9%) | -$108.58 M(-9.6%) |
| Jun 2022 | - | -$25.39 M(+80.6%) | -$120.08 M(-13.5%) |
| Mar 2022 | - | -$14.06 M(-70.4%) | -$138.76 M(-12.4%) |
| Dec 2021 | -$147.70 M(-13.0%) | -$47.53 M(+43.6%) | -$158.38 M(-8.8%) |
| Sep 2021 | - | -$33.09 M(-24.9%) | -$173.74 M(-3.6%) |
| Jun 2021 | - | -$44.07 M(+30.8%) | -$180.21 M(+4.4%) |
| Mar 2021 | - | -$33.69 M(-46.4%) | -$172.63 M(+1.7%) |
| Dec 2020 | -$169.73 M(+20.6%) | -$62.89 M(+58.9%) | -$169.73 M(+16.9%) |
| Sep 2020 | - | -$39.57 M(+8.4%) | -$145.20 M(+6.8%) |
| Jun 2020 | - | -$36.49 M(+18.5%) | -$135.93 M(+1.7%) |
| Mar 2020 | - | -$30.79 M(-19.7%) | -$133.65 M(-5.0%) |
| Dec 2019 | -$140.70 M(+9.7%) | -$38.35 M(+26.6%) | -$140.70 M(+1.1%) |
| Sep 2019 | - | -$30.29 M(-11.5%) | -$139.22 M(+1.4%) |
| Jun 2019 | - | -$34.21 M(-9.6%) | -$137.35 M(+56.7%) |
| Mar 2019 | - | -$37.84 M(+2.6%) | -$87.63 M(+25.5%) |
| Dec 2018 | -$128.27 M(+10.7%) | -$36.88 M(+29.8%) | -$69.80 M(-23.2%) |
| Sep 2018 | - | -$28.42 M(-283.3%) | -$90.91 M(+13.3%) |
| Jun 2018 | - | $15.51 M(-177.5%) | -$80.24 M(-29.7%) |
| Mar 2018 | - | -$20.01 M(-65.5%) | -$114.21 M(-1.5%) |
| Dec 2017 | -$115.89 M(+85.0%) | -$57.99 M(+226.8%) | -$115.89 M(+52.6%) |
| Sep 2017 | - | -$17.75 M(-3.9%) | -$75.94 M(+3.0%) |
| Jun 2017 | - | -$18.47 M(-14.9%) | -$73.74 M(-4.6%) |
| Mar 2017 | - | -$21.70 M(+20.3%) | -$77.30 M(+23.4%) |
| Dec 2016 | -$62.65 M(+45.1%) | -$18.03 M(+16.0%) | -$62.65 M(+30.7%) |
| Sep 2016 | - | -$15.55 M(-29.4%) | -$47.95 M(-2.0%) |
| Jun 2016 | - | -$22.03 M(+212.6%) | -$48.93 M(+81.1%) |
| Mar 2016 | - | -$7.05 M(+111.8%) | -$27.01 M(-37.4%) |
| Dec 2015 | -$43.16 M(+23.5%) | -$3.33 M(-79.9%) | -$43.16 M(+6.1%) |
| Sep 2015 | - | -$16.53 M(>+9900.0%) | -$40.70 M(+36.2%) |
| Jun 2015 | - | -$111.00 K(-99.5%) | -$29.87 M(-8.5%) |
| Mar 2015 | - | -$23.20 M(+2584.7%) | -$32.65 M(-6.6%) |
| Dec 2014 | -$34.95 M(+1.5%) | -$864.00 K(-84.8%) | -$34.95 M(-5.7%) |
| Sep 2014 | - | -$5.70 M(+97.4%) | -$37.06 M(-14.4%) |
| Jun 2014 | - | -$2.89 M(-88.7%) | -$43.28 M(-17.9%) |
| Mar 2014 | - | -$25.50 M(+757.0%) | -$52.68 M(+52.5%) |
| Dec 2013 | -$34.44 M(-142.8%) | -$2.98 M(-75.0%) | -$34.54 M(+65.4%) |
| Sep 2013 | - | -$11.92 M(-3.1%) | -$20.88 M(-247.7%) |
| Jun 2013 | - | -$12.29 M(+67.2%) | $14.14 M(-71.4%) |
| Mar 2013 | - | -$7.35 M(-168.8%) | $49.47 M(-38.5%) |
| Dec 2012 | $80.42 M(+42.2%) | $10.68 M(-53.8%) | $80.42 M(-0.5%) |
| Sep 2012 | - | $23.11 M(+0.4%) | $80.81 M(+6.7%) |
| Jun 2012 | - | $23.03 M(-2.4%) | $75.75 M(+20.9%) |
| Mar 2012 | - | $23.60 M(+113.1%) | $62.63 M(+10.8%) |
| Dec 2011 | $56.55 M(-210.6%) | $11.07 M(-38.7%) | $56.55 M(+4.7%) |
| Sep 2011 | - | $18.05 M(+82.0%) | $53.99 M(+85.8%) |
| Jun 2011 | - | $9.92 M(-43.4%) | $29.07 M(+322.3%) |
| Mar 2011 | - | $17.51 M(+105.5%) | $6.88 M(-113.5%) |
| Dec 2010 | -$51.12 M(+79.3%) | $8.52 M(-223.9%) | -$51.12 M(-25.8%) |
| Sep 2010 | - | -$6.88 M(-43.9%) | -$68.93 M(-2.7%) |
| Jun 2010 | - | -$12.27 M(-69.7%) | -$70.81 M(+3.6%) |
| Mar 2010 | - | -$40.49 M(+335.9%) | -$68.37 M(+139.8%) |
| Dec 2009 | -$28.51 M | -$9.29 M(+6.0%) | -$28.51 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$8.76 M(-10.9%) | -$26.32 M(-1.2%) |
| Jun 2009 | - | -$9.83 M(+1470.4%) | -$26.65 M(+335.2%) |
| Mar 2009 | - | -$626.00 K(-91.2%) | -$6.12 M(-57.7%) |
| Dec 2008 | -$14.46 M(-61.1%) | -$7.11 M(-21.9%) | -$14.46 M(-30.3%) |
| Sep 2008 | - | -$9.09 M(-185.0%) | -$20.74 M(+3.9%) |
| Jun 2008 | - | $10.70 M(-219.3%) | -$19.96 M(-47.0%) |
| Mar 2008 | - | -$8.97 M(-33.0%) | -$37.69 M(+1.3%) |
| Dec 2007 | -$37.20 M(+43.6%) | -$13.38 M(+61.1%) | -$37.20 M(+46.1%) |
| Sep 2007 | - | -$8.31 M(+18.2%) | -$25.46 M(+1.0%) |
| Jun 2007 | - | -$7.03 M(-17.1%) | -$25.21 M(-9.5%) |
| Mar 2007 | - | -$8.47 M(+413.9%) | -$27.86 M(+7.6%) |
| Dec 2006 | -$25.89 M(+30.0%) | -$1.65 M(-79.5%) | -$25.89 M(-8.7%) |
| Sep 2006 | - | -$8.06 M(-16.7%) | -$28.36 M(+10.0%) |
| Jun 2006 | - | -$9.68 M(+48.7%) | -$25.79 M(+23.2%) |
| Mar 2006 | - | -$6.51 M(+58.0%) | -$20.94 M(+5.1%) |
| Dec 2005 | -$19.92 M(+55.6%) | -$4.12 M(-25.0%) | -$19.92 M(+2.3%) |
| Sep 2005 | - | -$5.49 M(+13.8%) | -$19.48 M(+6.8%) |
| Jun 2005 | - | -$4.83 M(-12.0%) | -$18.23 M(+13.5%) |
| Mar 2005 | - | -$5.48 M(+49.1%) | -$16.07 M(+25.5%) |
| Dec 2004 | -$12.80 M(+24.2%) | -$3.68 M(-13.4%) | -$12.80 M(-5.3%) |
| Sep 2004 | - | -$4.25 M(+59.7%) | -$13.52 M(+13.9%) |
| Jun 2004 | - | -$2.66 M(+19.9%) | -$11.87 M(+9.3%) |
| Mar 2004 | - | -$2.22 M(-49.6%) | -$10.86 M(+5.0%) |
| Dec 2003 | -$10.30 M(-28.7%) | -$4.39 M(+69.1%) | -$10.34 M(+32.0%) |
| Sep 2003 | - | -$2.60 M(+57.7%) | -$7.83 M(+22.9%) |
| Jun 2003 | - | -$1.65 M(-2.9%) | -$6.37 M(-34.8%) |
| Mar 2003 | - | -$1.70 M(-10.1%) | -$9.77 M(-32.4%) |
| Dec 2002 | -$14.46 M(-48.6%) | -$1.89 M(+66.0%) | -$14.46 M(-34.8%) |
| Sep 2002 | - | -$1.14 M(-77.4%) | -$22.16 M(-18.6%) |
| Jun 2002 | - | -$5.05 M(-20.9%) | -$27.23 M(-5.8%) |
| Mar 2002 | - | -$6.38 M(-33.5%) | -$28.92 M(+2.8%) |
| Dec 2001 | -$28.15 M(-35.8%) | -$9.60 M(+54.6%) | -$28.15 M(-5.6%) |
| Sep 2001 | - | -$6.21 M(-7.8%) | -$29.81 M(-15.7%) |
| Jun 2001 | - | -$6.74 M(+20.1%) | -$35.38 M(-11.6%) |
| Mar 2001 | - | -$5.61 M(-50.2%) | -$40.03 M(-8.8%) |
| Dec 2000 | -$43.87 M(+86.5%) | -$11.25 M(-4.5%) | -$43.87 M(+3.6%) |
| Sep 2000 | - | -$11.78 M(+3.4%) | -$42.34 M(+18.1%) |
| Jun 2000 | - | -$11.39 M(+20.4%) | -$35.87 M(+25.9%) |
| Mar 2000 | - | -$9.46 M(-2.8%) | -$28.48 M(+21.6%) |
| Dec 1999 | -$23.52 M(+102.8%) | -$9.72 M(+83.5%) | -$23.42 M(+35.4%) |
| Sep 1999 | - | -$5.30 M(+32.5%) | -$17.30 M(+16.1%) |
| Jun 1999 | - | -$4.00 M(-9.1%) | -$14.90 M(+10.4%) |
| Mar 1999 | - | -$4.40 M(+22.2%) | -$13.50 M(+17.4%) |
| Dec 1998 | -$11.60 M(+70.6%) | -$3.60 M(+24.1%) | -$11.50 M(+11.7%) |
| Sep 1998 | - | -$2.90 M(+11.5%) | -$10.30 M(+10.8%) |
| Jun 1998 | - | -$2.60 M(+8.3%) | -$9.30 M(+16.3%) |
| Mar 1998 | - | -$2.40 M(0.0%) | -$8.00 M(+19.4%) |
| Dec 1997 | -$6.80 M(+466.7%) | -$2.40 M(+26.3%) | -$6.70 M(+31.4%) |
| Sep 1997 | - | -$1.90 M(+46.2%) | -$5.10 M(+50.0%) |
| Jun 1997 | - | -$1.30 M(+18.2%) | -$3.40 M(+70.0%) |
| Mar 1997 | - | -$1.10 M(+37.5%) | -$2.00 M(+150.0%) |
| Dec 1996 | -$1.20 M | -$800.00 K(+300.0%) | -$800.00 K(<-9900.0%) |
| Sep 1996 | - | -$200.00 K(-300.0%) | $0.00(-100.0%) |
| Jun 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is Spectrum Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals annual EBIT year-on-year change?
- What is Spectrum Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals quarterly EBIT year-on-year change?
- What is Spectrum Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals TTM EBIT year-on-year change?
What is Spectrum Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SPPI is -$77.06 M
What is the all time high annual EBIT for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high annual earnings before interest & taxes is $80.42 M
What is Spectrum Pharmaceuticals annual EBIT year-on-year change?
Over the past year, SPPI annual earnings before interest & taxes has changed by +$70.64 M (+47.83%)
What is Spectrum Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SPPI is -$4.06 M
What is the all time high quarterly EBIT for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high quarterly earnings before interest & taxes is $23.60 M
What is Spectrum Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SPPI quarterly earnings before interest & taxes has changed by +$10.00 M (+71.11%)
What is Spectrum Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SPPI is -$67.06 M
What is the all time high TTM EBIT for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high TTM earnings before interest & taxes is $80.81 M
What is Spectrum Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SPPI TTM earnings before interest & taxes has changed by +$71.70 M (+51.67%)